Venetoclax 100mg price

Venetoclax (Venetoclax) is a BCL-2 inhibitor that is administered orally. The common specifications are venetoclax tablets, which contain 10mg, 50mg or 100mg of Venetoclax as the main active ingredient. After Venclexta was launched on the market, it was sold in many countries under the trade names of Venclexta, Venclyxto and Venclyxto.

Venetoclax is approved for the treatment of newly diagnosed acute myeloid leukemia, including adults 75 years and older or who are unable to receive intensive induction chemotherapy, when used with azacitidine, decitabine, or low-dose cytarabine. Veneclat is also indicated for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma, either alone or in combination with obinutuzumab or rituximab. Veneclat is also being studied to treat other types of cancer.

The original drug of Venacla has been launched in China and can be found in the Category B medical insurance directory. The price of 100mg*14 tablets per box may be around RMB 5,000, and the price of 100mg*28 tablets per box may be more than RMB 2,000. The Turkish version of Venaclaoriginal drug, specifications100mg*112 tablets, sold overseas, costs around RMB 10,000 per box (the price may fluctuate due to exchange rates), which is even more expensive. Cheaper generic drugs are also sold overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs. The price of a box of 100mg*120 tablets produced by a Bangladeshi pharmaceutical factory is around RMB 4,000 (prices may fluctuate due to exchange rates).